Oral Candidiasis in Patients with Level CD4+ Below 50
DOI:
https://doi.org/10.18196/di.v13i1.20003Keywords:
oral candidiasis, HIV, AIDS, CD4Abstract
Approximately 90% of individuals diagnosed with HIV/AIDS have encountered Oral Candidiasis during the progression of their disease, especially in patients with a reduced CD4+ 200 mm3. Oral Candidiasis is a prevalent opportunistic infection of the oral cavity. Reported a case of a patient with oral candidiasis in an HIV/AIDS with CD4+ below 50 and discussed the mechanism of molecular relationship decreasing count CD4+ with virulence of Candida Albicans. In this report, we present a case of a 35-year-old female who presented with oral candidiasis. The patient's CD4+ count test revealed a level below 50 and HIV test I-II-III reactive. Human immunodeficiency Virus causes a decrease in CD4+ count and leads to opportunistic oral candidiasis infection.
References
Femilian A, Masuku WDM, Ayuningtyas NF, Ernawati DS, Mahdani FY, Surboyo MDC. Clinical appearance of acute pseudomembranous candidiasis in children and the importance of good communication, information and education to patients: A case report. Dent J. 2022;55(2):105–8. https://doi.org/10.20473/j.djmkg.v55.i2.p105-108
Macias-Paz IU, Pérez-Hernández S, Tavera-Tapia A, Luna-Arias JP, Guerra-Cárdenas JE, Reyna-Beltrán E. Candida albicans the main opportunistic pathogenic fungus in humans. Rev Argent Microbiol 2022;55(2):189–98. https://doi.org/10.1016/j.ram.2022.08.003
Sharma G, Oberoi SS, Vohra P, Nagpal A. Oral manifestations of HIV/AIDS in Asia: Systematic review and future research guidelines. J Clin Exp Dent. 2015;7(3):e419–27. https://doi.org/10.4317/jced.52127
Murtiastutik D, Prakoswa CRS, Tantular IS, Ervianti E, Hidayati AN, Listiawan MY. Correlation between CD4 T lymphocyte and candida species counts in oral candidiasis patients with HIV / AIDS. Indian J Forensic Med Toxicol. 2021;15(1):1013–20. https://doi.org/10.37506/ijfmt.v15i1.13548
Ersha RF, Ahmad A. Human Immunodeficiency Virus – Acquired Immunodeficiency Syndrome dengan Sarkoma Kaposi. J Kesehat Andalas. 2018;7(Supplement 3):131. https://doi.org/10.25077/jka.v7i0.875
Kirti YK. Prevalence of Oral Candidiasis in Indian HIV Sero-Positive Patients with CD4 + Cell Count Correlation. Indian J Otolaryngol Head Neck Surg 2019;71(1):124–7. https://doi.org/10.1007/s12070-018-1342-3
Cunningham AL, Donaghy H, Harman AN, Kim M, Turville SG. Manipulation of dendritic cell function by viruses. Curr Opin Microbiol. 2010;13(4):524–9. https://doi.org/10.1016/j.mib.2010.06.002
Garg H, Mohl J, Joshi A. HIV-1 induced bystander apoptosis. Viruses. 2012;4(11):3020–43. https://doi.org/10.3390/v4113020
Klatt NR, Estes JD, Sun X, Ortiz AM, Barber JS, Harris LD, et al. Loss of CD103+ Dcs and Mucosal IL-17+ and IL-22+ Lymphocytes is Associated with Mucosal Damage in SIV Infection. 2013;5(6):646–57. https://doi.org/10.1038/mi.2012.38
Miró MS, Caeiro JP, Rodriguez E, Vargas L, Vigezzi C, Icely PA, et al. Candida albicans Modulates Murine and Human Beta Defensin-1 during Vaginitis. J Fungi. 2022;8(1):1–18. https://doi.org/10.3390/jof8010020
Mengesha BG, Conti HR. The role of IL-17 in protection against mucosal Candida infections. J Fungi. 2017;3(4). https://doi.org/10.3390/jof3040052
Urban CF, Nett JE. Neutrophil extracellular traps in fungal infection. Semin Cell Dev Biol. 2019;89:47–57. https://doi.org/10.1016/j.semcdb.2018.03.020
Burket LW. Burket’s Oral Medicine. thirteenth. Glick M, Greenberg MS, Lockhart PB, Challacombe SJ, editors. Newyork, USA: Wiley Blackwell; 2021.
Radithia D, Soebadi B, Hendarti HT, Surboyo MDC, Ayuningtyas NF, Triyono EA. Dental-related problems and oral manifestation of hiv/aids patients in soetomo general hospital surabaya. Bali Med J. 2020;9(2):537–41. https://doi.org/10.15562/bmj.v9i2.1291
Ghom AG. Textbook of Oral Medicine. Jaypee Brothers Medical Ltd; 2014.
16. Desai J V. Candida albicans hyphae: From growth initiation to invasion. J Fungi. 2018;4(1). https://doi.org/10.3390/jof4010010
Henriques M, Silva S. Candida albicans virulence factors and its pathogenicity. Microorganisms. 2021;9(4):11–3. https://doi.org/10.3390/microorganisms9040704
Talapko J, Juzbašić M, Matijević T, Pustijanac E, Bekić S, Kotris I, et al. Candida albicans-the virulence factors and clinical manifestations of infection. J Fungi. 2021;7(2):1–19. https://doi.org/10.3390/jof7020079
Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: A disease of opportunity. J Fungi. 2020;6(1):1–28. https://doi.org/10.3390/jof6010015
Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence. 2022;13(1):89–121. https://doi.org/10.1080/21505594.2021.2019950
Li W, Yu D, Gao S, Lin J, Chen Z, Zhao W. Role of Candida Albicans-secreted aspartyl proteinases (Saps) in severe early childhood caries. Int J Mol Sci. 2014;15(6):10766–79. https://doi.org/10.3390/ijms150610766
Zand F, Zahed L, Mansouri P, Dehghanrad F, Bahrani M, Ghorbani M. The effects of oral rinse with 0.2% and 2% chlorhexidine on oropharyngeal colonization and ventilator associated pneumonia in adults’ intensive care units. J Crit Care. https://doi.org/10.1016/j.jcrc.2017.02.029
Somayaji S, Gadahad MR, Lakshminarayana S. Antimicrobial efficacy of chlorine dioxide against Candida albicans in stationary and starvation phases in human root canal: An in-vitro study. Sahel Med J. 2014;17(1):1. https://doi.org/10.4103/1118-8561.129144
Rai A, Misra SR, Panda S, Sokolowski G, Mishra L, Das R, et al. Nystatin Effectiveness in Oral Candidiasis Treatment: A Systematic Review & Meta-Analysis of Clinical Trials. Life. 2022;12(11). https://doi.org/10.3390/life12111677
Downloads
Additional Files
Published
Issue
Section
License
License
Insisiva Dental Journal : Majalah Kedokteran Gigi Insisiva (IDJ) is licensed under an Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially. This license is acceptable for Free Cultural Works.
The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Copyright
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under an Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).